Skip to content

VALIDATION OF ACTIVE PHARMACEUTICAL INGREDIENTS 2ED (HB 2008)
Stock Photo: Cover May Be Different

VALIDATION OF ACTIVE PHARMACEUTICAL INGREDIENTS 2ED (HB 2008) Hardcover - 2001 - 2nd Edition

by Ira R. Berry (Editor); Daniel Harpaz (Editor)

  • New

Description

SR-ECOMMERCE. New.
New
NZ$249.03
NZ$24.91 Shipping to USA
Standard delivery: 20 to 30 days
More Shipping Options
Ships from Sanctum Books (Delhi, India)

About Sanctum Books Delhi, India

Biblio member since 2010
Seller rating: This seller has earned a 5 of 5 Stars rating from Biblio customers.

We are leading publishers, booksellers, distributors, importers, and exporters. We carry a large selection of books on varied subjects. Do place your valued order or let us know your requirement via email.

Terms of Sale:

30 day return guarantee, with full refund including shipping costs for up to 30 days after delivery if an item arrives misdescribed or damaged.

We accept VISA/MasterCard/American Express. We also accept payments by PayPal in favour of orders@sanctumbooks.com, Bank Draft (Banker's Cheque) favouring Sanctum Books, or Bank Transfer (Account no. 0031167221, Swift Code: CITIINBX, Citibank, Jeevan Bharati Building, Connaught Circus, New Delhi 110 001, India). Cheques may be made payable to Sanctum Books, New Delhi. Books are shipped by registered Air Mail or SAL (Surface Air Lifted). Additional shipping charges may be required for multi-volume sets.

Browse books from Sanctum Books

Details

  • Title VALIDATION OF ACTIVE PHARMACEUTICAL INGREDIENTS 2ED (HB 2008)
  • Binding Hardcover
  • Edition number 2nd
  • Edition 2
  • Condition New
  • Pages 618
  • Volumes 1
  • Language ENG
  • Publisher SR-ECOMMERCE
  • Date 2001-12-31
  • Bookseller's Inventory # SrEcom-9781574911190
  • ISBN 9781574911190 / 1574911198
  • Weight 2.68 lbs (1.22 kg)
  • Dimensions 10.35 x 7.07 x 1.37 in (26.29 x 17.96 x 3.48 cm)
  • Library of Congress Catalog Number 00143894
  • Dewey Decimal Code 615.19

First line

The subjects of Good Manufacturing Practice (GMP) and validation are not new to the pharmaceutical industry (Berry and Nash 1993; Tetzlaff et al. 1993; Berry 1988; Reisman 1995; Agalloco 1995; FDA 1987, 1994a, 1993a; Tetzlaff 1992a, 1992b; Tetzlaff 1993; Harpaz 1996; Amer 2000).